A PROVIDER QUESTION KIT
Tirzepatide Clinic Directory: check the care, not the pitch
A plain-language guide to understanding tirzepatide and checking a clinic or telehealth service found elsewhere.
No clinic listings here: this directory is a list of checks to run on any clinic you find.
BEHIND THE TIRZEPATIDE PITCH
Real medicine. Real checks.
As of September 2026, tirzepatide was FDA-approved under two names: Mounjaro was the diabetes brand, while Zepbound covered chronic weight care and certain adults with obesity and sleep apnea.
FDA records dated September 2026 showed no approved US generic for tirzepatide.
With compounding, a pharmacy or doctor prepares the drug for one patient by hand, rather than dispensing a factory-sealed product made by a manufacturer.
As of September 2026, a compounded version of tirzepatide was still not FDA-approved, even when the pharmacy that made it held a state licence.
The useful question is not “Is this clinic popular?” It is “Can the service name the clinician, the product, the pharmacy, the total cost, and the follow-up plan?”
THE FOUR CHECKS
Leave with names, not slogans
- CLINICIAN
Who reviews the case?
Get a full name, role, and a route to the state licence record.
- PRODUCT
What exactly is offered?
Get the drug name, whether it is the brand-name product or a pharmacy-made (compounded) copy, whether it comes as a pen or a vial, and who made it.
- PHARMACY
Who sends it?
Get the pharmacy name before payment, then check the state record.
- PLAN
What happens next?
Get the full price, follow-up path, and a clear way to ask questions.
CHOOSE A FILE